A new study published in the International Journal of General Medicine showed that by focusing on mast cells and inflammatory ...

"2025 was a year that demonstrated Bambusa's execution-first culture," said Dr. Xu. "With multiple clinical programs advancing in parallel, we are entering 2026 positioned to deliver up to 10 clinical ...

New York Army National Guard Command Sgt. Maj. Curtis L. Moss was recognized for 30 years of exemplary service.

His elbow moved normally, his thighs were supple, his shoulder pain had disappeared, and the skin tightening had eased ...

In Nation Healthcare Security Administration’s (NHSA’s) announcement for the 2025 NRDL, the government’s support for ...

An elevated neutrophil-to-lymphocyte ratio (NLR) is significantly associated with increased risk of depressive disorder (DD) ...

The US FDA approved 46 new drugs in 2025, despite a tumultuous year at the regulatory agency.

Throughout 2025, AbbVie’s Skyrizi and Johnson & Johnson’s Tremfya were mainstays at the top of the monthly TV drug ad ...

Neurodevelopmental disorders are a group of disorders in which the development of the central nervous system is disturbed. This can include developmental brain dysfunction, which can manifest as ...

Diagnostic delays of 10 to 15 years are common among people with bipolar disorder, research shows. Here’s what two people with the condition have to say about experiences that, in hindsight, they ...

GSK has secured approval in Japan for Exdensur (depemokimab), the country’s first ultra-long-acting biologic for severe asthma and chronic rhinosinusitis with nasal polyps. Approved by Japan’s ...